Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
about
Nanobacteria are mineralo fetuin complexesPepper mild mottle virus, a plant virus associated with specific immune responses, Fever, abdominal pains, and pruritus in humansImmunogenicity of self-associated aggregates and chemically cross-linked conjugates of the 42 kDa Plasmodium falciparum merozoite surface protein-1Revised Mimivirus major capsid protein sequence reveals intron-containing gene structure and extra domainMicroarray for serotyping of Bartonella species.Plasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.Optimal seasonal timing of oral azithromycin for malaria.CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccineLong-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.Vaccination with novel immunostimulatory adjuvants against blood-stage malaria in mice.Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.Synthetic Toll-like receptor 4 agonist enhances vaccine efficacy in an experimental model of toxic shock syndrome.Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.Improving vaccines by incorporating immunological coadjuvants.TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models.Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
P2860
Q21090525-A5029ACD-EF04-42EC-924B-401655AE43B0Q21091139-1B77AD87-C368-40E6-B4FF-5D9D9AA0CF79Q28484081-9B7F7AF0-2535-463F-AE6E-24FCAC2BB7B5Q30376975-3EB9C6BF-9C42-40FD-A2D4-7BDB85E8AF3DQ33288921-617B544B-EA6D-4E91-979E-8C1B30554CB6Q33742070-768C5959-9950-48B6-839C-BF3E527F33FFQ34496220-A0BD96A2-DD5A-4F9F-A46E-9DEFE89DC463Q35550770-AB35B6BA-8337-4ADD-A57A-827B82762E14Q35783529-6D5485AC-CE62-47C8-ACDD-E0ECA4B0EC9AQ35801755-2EB3141E-FC3F-46DD-B481-D6A8097BC992Q36228960-21D6A72D-257C-4555-AC9D-84583D4C8A91Q36313592-3F0A3C3C-9419-4DB5-9C38-DBE68C7D6AB1Q36718066-969ADCDD-509A-45DB-88E0-54CBFE8A2A2BQ36899084-53AD1F91-C36C-42C0-95D1-FD86394D5578Q37384724-65C02F27-CDBA-4077-B630-81E92908B5F0Q47964774-D9C2707C-4886-4BDE-9DCC-03D881C2DEC6Q47989426-0D9B5EB9-0A4A-48FF-80C5-EA54D421932A
P2860
Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Improved immunogenicity and ef ...... murine malaria vaccine model.
@ast
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
Improved immunogenicity and ef ...... murine malaria vaccine model.
@nl
type
label
Improved immunogenicity and ef ...... murine malaria vaccine model.
@ast
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
Improved immunogenicity and ef ...... murine malaria vaccine model.
@nl
prefLabel
Improved immunogenicity and ef ...... murine malaria vaccine model.
@ast
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
Improved immunogenicity and ef ...... murine malaria vaccine model.
@nl
P2093
P2860
P1476
Improved immunogenicity and ef ...... murine malaria vaccine model.
@en
P2093
Anthony W Stowers
David C Kaslow
Dragana Jankovic
Karen A Near
P2860
P304
P356
10.1128/IAI.70.2.692-701.2002
P407
P577
2002-02-01T00:00:00Z